Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

TitleSequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
Publication TypeJournal Article
Year of Publication2005
AuthorsAbikoff, H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L
Corporate AuthorsRUPP ADHD/Anxiety Study Group
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume44
Issue5
Pagination418-27
Date Published2005 May
ISSN0890-8567
KeywordsAdolescent, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Child, Comorbidity, Dose-Response Relationship, Drug, Double-Blind Method, Female, Fluvoxamine, Humans, Male, Methylphenidate, Serotonin Uptake Inhibitors
Abstract

Attention-deficit/hyperactivity disorder (ADHD) is often accompanied by clinically significant anxiety, but few empirical data guide treatment of children meeting full DSM-IV criteria for ADHD and anxiety disorders (ADHD/ANX). This study examined the efficacy of sequential pharmacotherapy for ADHD/ANX children.

DOI10.1016/j.comppsych.2011.05.003
Alternate JournalJ Am Acad Child Adolesc Psychiatry